Search for: "Bristol Myers Squibb Manufacturing Company"
Results 61 - 80
of 162
Sorted by Relevance
|
Sort by Date
29 Feb 2012, 7:24 am
Squibbs and Sons (now known as Bristol-Myers Squibb) and many other companies including 70 other similar types of synthetic hormones . [read post]
9 Aug 2010, 3:07 pm
--Collazo v Bristol-Myers Squibb Manufacturing, Inc, (1st Circuit): An interesting one here. [read post]
28 Jun 2017, 8:34 am
Ability’s manufacturers, Otsuka and Bristol-Myers Squibb, are facing a growing number of lawsuits from patients who claim they couldn’t control the urge to gamble or over-eat, or that they developed hyper sexual behaviors. [read post]
26 Mar 2021, 5:56 pm
What is of particular interest to our readers is the Court’s re-emphasis of the meaning of Bristol-Myers Squibb Co. v. [read post]
13 Feb 2015, 12:00 pm
At issue in the case were Bristol-Myers Squibb’s anticoagulant Coumadin and AstraZeneca’s ulcer drugs Prilosec and Nexium. [read post]
20 Nov 2007, 7:18 am
Maxipime is manufactured by Bristol-Myers Squibb Co. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
26 Jun 2015, 11:30 am
Our readers already know that it took the California Supreme Court less than four months to depublish Bristol-Myers Squibb (reported here). [read post]
10 Nov 2015, 3:41 am
Don’t forget to tune in today for the webcast – “How to Draft Meaningful Sustainability Reports” – to hear Lou Coppola of the Governance & Accountability Institute, Kate Kelly of Bristol-Myers Squibb and Pam Styles of Next Level Investor Relations explain the keys to drafting sustainability reports that are meaningful to investors & other constituents and a “how to” list of things you should be aware of when drafting. [read post]
28 Jul 2013, 9:29 am
Januvia and Janumet (Manufactured by Merck) Bydureon (Made by Bristol-Myers Squibb) Onglyza (Made by AstraZeneca) Victoza (Manufactured by Novo Nordisk) Tradjenta (Manufactured by both Eli Lilly and Boehringer Ingelheim; Actos (Manufactured from Takeda) Click here to view the embedded video. . . . [read post]
11 Jan 2013, 6:27 pm
The patents for the remaining two drugs – Ixabepilone and Dastinib are owned by Bristol Myers Squibbs (BMS). [read post]
4 Sep 2012, 1:45 pm
Experts further expected that the new drug will generate more sales to its manufacturer since its competing experimental drug from Bristol-Myers Squibb. [read post]
28 Jul 2011, 3:33 pm
(6) Is it of significance in answering Question 1 that the repackaging company is indicated as the manufacturer in the package leaflet? [read post]
30 Apr 2013, 12:14 pm
Bristol-Myers Squibb Company, 2013 U.S. [read post]
3 Jul 2017, 6:15 am
In Bristol-Myers Squibb Company v. [read post]
19 Jun 2015, 6:30 am
Food and Drug Administration (FDA) approved the first AB-rated generics to Bristol-Myers Squibb and Otsuka’s Abilify® (aripiprazole) tablets, an atypical antipsychotic drug commonly used for treating schizophrenia and bipolar disorder. [read post]
15 Dec 2020, 5:00 am
Supreme Court opinions, the most recent of which was in the case of Bristol-Myers Squibb v. [read post]
24 Jan 2013, 11:49 am
Bristol-Myers Squibb Co., No. 06-6050 (FLW) (D.N.J. [read post]
13 Feb 2013, 11:49 pm
For those interested, the Indian patent number is 213457 and the case details are: Bristol-Myers Squibb Company v. [read post]
